2021
Biotech firm CellResearch pioneers stem cell treatment for diabetic foot ulcers
December 20, 2021. The Straits Times
The company has since pioneered a stem cell therapy to treat chronic diabetic foot ulcers, which affect more than 30 million people globally.
These ulcers are open sores or wounds that may result from poor blood circulation or a lack of sensation due to nerve damage caused by elevated blood glucose levels.
MHRA Awards ‘Innovation Passport’ to CellResearch for Stem Cell Therapy
October 14, 2021. PharmTech.com
The Medicines and Healthcare products Regulatory Agency (MHRA) — regulatory body of the United Kingdom — has awarded an ‘Innovation Passport’ to CellResearch, a Singaporean biotech, for CorLiCyte — an umbilical cord lining stem cell therapy.
The UK approves umbilical cord lining stem cell therapy by a Singapore firm
October 13, 2021. BioSpectrum Asia
Singapore's biotech CellResearch Corporation receives the Innovation Passport to accelerate umbilical cord lining stem cell therapy (CorLiCyte), for Diabetic Foot Ulcer (DFU) in the UK.
2020
A stem cell trial for diabetic foot ulcers
November 17, 2020. UCHealth
UCHealth is part of a collaborative campus trial testing the safety of umbilical cord stem cells to treat diabetic foot ulcers, a devastating complication of the disease.
2019
$80m boost to turn manufacture of cells into a big money-spinner
March 28, 2019. The Straits Times
Cell therapy, where living cells are harnessed to treat or prevent disease, is hailed as the future of medicine. But the bottleneck is in producing good-quality cells cost-effectively and in large quantities.
Stem Cells in Regenerative Medicine
December 13, 2019. Aesthetics Journal
It is an urban myth that household dust comprises 80% of shed human skin. But why is human skin even shed at all? This is one example of many continuous regenerative processes that take place in the body at any one time, occurring at a background level that is barely discernible, in spite of the skin being the largest organ of the human body.
2018
CALECIM® Professional Unveils Unique Cord-Lining Stem Cell Technology As The Latest Advance In Cosmeceutical Skincare
February 26, 2018. PRIME Journal
Renowned dermatologist and cosmetic surgeon Dr Mitchel Goldman unveiled the globally-patented technology behind CALECIM® Professional.
2017
Singapore-based CellResearch considering Nasdaq listing
July 18, 2017. Singapore Business Times
The company holds 41 patents in regenerative medicine, including a topical treatment for chronic wounds.
2016
FDA trial for S'pore biomedical company
November 25, 2016. The Straits Times
Diabetic wounds are notoriously difficult to treat, but a Singapore biomedical firm believes it has succeeded in doing so, and has received the nod from the United States Food and Drug Administration (FDA) to test its treatment on patients.
Stem cell researcher Phan Toan Thang: Birthing new skin with umbilical cord stem cells
June 20, 2016. The Straits Times
Wounds may cause some to look away, but stem cell researcher Phan Toan Thang sees "magic" in them. "I like wounds. I see the wound healing. It's something amazing," he said. The chief scientist's passion for healing wounds led him to discover a way to create skin cells quickly and in large quantities by using the lining from umbilical cords.
Selling Wonder Cells
May 27, 2016. Storm Asia
There’s no such thing as the fountain of youth. There is, however, science, and the possibilities that stem cell research offers.
The Peak Interview: Cellresearch Corp CEO Gavin Tan Intends to Heal the World
May 5, 2016. The PEAK
Singapore stem cell research company CEO turned down untold fortunes to allow company's technology to help more people. “We have been given not just the ‘cup’, but a roomful of this stuff (stem cells) and we have to make sure everyone has access to it.”
Cordlife invests $8.4 million more in alliance with CellResearch Corp
February 1, 2016. The Edge
Healthcare company Cordlife Group said today it has invested a further $8.4 million in its strategic alliance with CellResearch Corporation.
Hard Cell
January 23, 2016. The Business Times
Transcending placenta creams and illegal injections, the latest in stem cell technology developed by a homegrown company is the real deal in cutting-edge, anti-ageing cosmetics.
2015
Beauty brand scores with stem cells
December 24, 2015. The Straits Times
Home-grown Calecim uses red deer stem cells, believed to have cell-regenerating properties, in its cosmetics.
Stem cell skincare product goes global
August 13, 2015. The Straits Times
Singapore stem cell research company CellResearch Corp intends to be a global leader in the skincare market.
S'pore scientists see way to help Parkinson's patients
August 7, 2015. The Straits Times
Scientists in Singapore have potentially found a way to repair damaged brain cells in sufferers of Parkinson's disease by using stem cells from cord lining - spelling a possible breakthrough in combating the progressive neurological condition for which there is no effective treatment.
S'pore firm eyes global wound care market
June 28, 2015. The Straits Times
Home-grown biomedical company CellResearch Corporation, which has developed stem cell treatments for severe burns and injuries, has made its first advances into the multibillion-dollar international wound care market.
A wealth of possibilities
June 28, 2015. The Straits Times
By mining the umbilical cord lining, usually discarded when a woman gives birth, researchers have tapped into a rich source of stem cells versatile enough to transform into many of the body's cells.